Current and prospective pharmacotherapies for the treatment of pleural mesothelioma

Bakker, EY, Guazzelli, A, Krstic-Demonacos, M, Lisanti, MP, Sotgia, F and Mutti, L 2017, 'Current and prospective pharmacotherapies for the treatment of pleural mesothelioma' , Expert Opinion on Orphan Drugs, 5 (6) , pp. 455-465.

[img] PDF - Accepted Version
Restricted to Repository staff only until 23 May 2018.

Download (752kB) | Request a copy
[img] PDF - Published Version
Restricted to Repository staff only

Download (1MB) | Request a copy

Abstract

Introduction: Mesothelioma is a rare asbestos-linked cancer with an expected incidence peak between 2015–2030. Therapies remain ineffective, thus developing and testing novel treatments is important for both oncologists and researchers. Areas covered: After describing mesothelioma and the shortcomings of current therapies, the article discusses numerous therapies in turn such as immunotherapy (passive and active), gene therapy (such as suicide gene therapy) and targeted therapy such as tyrosine kinase inhibitors. The bases for different therapies and clinical trials at different phases are also described. The article concludes by detailing possible reasons for therapy failure. Expert opinion: Despite the many attempts to uncover new therapeutic options, mesothelioma is still an orphan disease, complicated by factors such as the inflammatory microenvironment and low mutational load. Our opinion is that uncovering the biological mechanisms behind mesothelioma development will assist therapy development. The lack of efficacy of tyrosine kinase inhibitors and modest anti-angiogenic activity indicates a less relevant role for tumor cell proliferation and neoangiogenesis, thus the shortcut of treating mesothelioma with therapies from other cancers may be unsound. Conversely, many lines of evidence indicate that focussing on the survival mechanisms that tumor cells exploit may yield better therapeutics, particularly nutrition and cellular machinery.

Item Type: Article
Schools: Schools > School of Environment and Life Sciences > Biomedical Research Centre
Journal or Publication Title: Expert Opinion on Orphan Drugs
Publisher: Taylor & Francis
ISSN: 2167-8707
Related URLs:
Depositing User: L Mutti
Date Deposited: 06 Jun 2017 13:24
Last Modified: 16 Oct 2017 03:12
URI: http://usir.salford.ac.uk/id/eprint/42519

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)

Downloads

Downloads per month over past year